ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog

Yutaka Akatsuka, Kensuke Egashira, Yousuke Katsuda, Takahiro Narishige, Hideki Ueno, Hiroaki Shimokawa, Akira Takeshita

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Objective: The aim was to determine a role of ATP sensitive potassium (KATP) channels in adenosine A2 receptor mediated coronary vasodilatation in anaesthetised dogs in vivo. Methods: Coronary blood flow in the left circumflex coronary artery, aortic pressure, and left ventricular pressure were measured during intracoronary infusions of the drugs into the left circumflex artery. Results: A non-selective A2 receptor agonist NECA (5'-N-ethylcarboxamidoadenosine) at 10-10-10-8 mol·min-1 before and after an A, receptor antagonist DPCPX (8-cyclopentyl-l,3-dipropylxanthine) increased coronary blood flow in a dose dependent manner, without affecting other haemodynamic variables. Glibenclamide at 10 μg·kg-1·min-1, which did not alter baseline haemodynamic variables, markedly inhibited the increases in coronary blood flow caused by NECA alone and after DPCPX (p<0.01). A non-selective adenosine receptor antagonist 8-phenyltheophylline abolished the NECA induced increases in coronary blood flow after DPCPX. These results suggest that A2 receptor mediated coronary vasodilatation was mediated largely by opening of KATP channels. Glibenclamide did not alter the increase in coronary blood flow evoked by forskolin or acetylcholine, suggesting that KATP channels may not be involved in coronary vasodilatation induced by activation of adenylate cyclase or guanylate cyclase. Furthermore, DPCPX increased basal coronary blood flow, which was blocked by 8-phenyltheophylline and by glibenclamide, suggesting that it may have unmasked A2 receptor mediated coronary vasodilatation by inhibiting the A1 receptor mediated vasoconstricting action of endogenous adenosine. Conclusions: Opening of KATP channels may be involved importantly in adenosine A2 receptor mediated coronary vasodilatation in canine hearts.Cardiovascular Research 1994:28:906-911.

Original languageEnglish
Pages (from-to)906-911
Number of pages6
JournalCardiovascular research
Volume28
Issue number6
DOIs
Publication statusPublished - Jan 1 1994

Fingerprint

Adenosine A2 Receptors
KATP Channels
Vasodilation
Adenosine-5'-(N-ethylcarboxamide)
Dogs
Glyburide
varespladib methyl
Hemodynamics
Purinergic P1 Receptor Antagonists
Guanylate Cyclase
Ventricular Pressure
Colforsin
Adenylyl Cyclases
Adenosine
Acetylcholine
Canidae
Coronary Vessels
Arterial Pressure
Arteries
1,3-dipropyl-8-cyclopentylxanthine

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog. / Akatsuka, Yutaka; Egashira, Kensuke; Katsuda, Yousuke; Narishige, Takahiro; Ueno, Hideki; Shimokawa, Hiroaki; Takeshita, Akira.

In: Cardiovascular research, Vol. 28, No. 6, 01.01.1994, p. 906-911.

Research output: Contribution to journalArticle

Akatsuka, Yutaka ; Egashira, Kensuke ; Katsuda, Yousuke ; Narishige, Takahiro ; Ueno, Hideki ; Shimokawa, Hiroaki ; Takeshita, Akira. / ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog. In: Cardiovascular research. 1994 ; Vol. 28, No. 6. pp. 906-911.
@article{28398cb997bc4130a399e460d3c597fe,
title = "ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog",
abstract = "Objective: The aim was to determine a role of ATP sensitive potassium (KATP) channels in adenosine A2 receptor mediated coronary vasodilatation in anaesthetised dogs in vivo. Methods: Coronary blood flow in the left circumflex coronary artery, aortic pressure, and left ventricular pressure were measured during intracoronary infusions of the drugs into the left circumflex artery. Results: A non-selective A2 receptor agonist NECA (5'-N-ethylcarboxamidoadenosine) at 10-10-10-8 mol·min-1 before and after an A, receptor antagonist DPCPX (8-cyclopentyl-l,3-dipropylxanthine) increased coronary blood flow in a dose dependent manner, without affecting other haemodynamic variables. Glibenclamide at 10 μg·kg-1·min-1, which did not alter baseline haemodynamic variables, markedly inhibited the increases in coronary blood flow caused by NECA alone and after DPCPX (p<0.01). A non-selective adenosine receptor antagonist 8-phenyltheophylline abolished the NECA induced increases in coronary blood flow after DPCPX. These results suggest that A2 receptor mediated coronary vasodilatation was mediated largely by opening of KATP channels. Glibenclamide did not alter the increase in coronary blood flow evoked by forskolin or acetylcholine, suggesting that KATP channels may not be involved in coronary vasodilatation induced by activation of adenylate cyclase or guanylate cyclase. Furthermore, DPCPX increased basal coronary blood flow, which was blocked by 8-phenyltheophylline and by glibenclamide, suggesting that it may have unmasked A2 receptor mediated coronary vasodilatation by inhibiting the A1 receptor mediated vasoconstricting action of endogenous adenosine. Conclusions: Opening of KATP channels may be involved importantly in adenosine A2 receptor mediated coronary vasodilatation in canine hearts.Cardiovascular Research 1994:28:906-911.",
author = "Yutaka Akatsuka and Kensuke Egashira and Yousuke Katsuda and Takahiro Narishige and Hideki Ueno and Hiroaki Shimokawa and Akira Takeshita",
year = "1994",
month = "1",
day = "1",
doi = "10.1093/cvr/28.6.906",
language = "English",
volume = "28",
pages = "906--911",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "6",

}

TY - JOUR

T1 - ATP sensitive potassium channels are involved in adenosine A2 receptor mediated coronary vasodilatation in the dog

AU - Akatsuka, Yutaka

AU - Egashira, Kensuke

AU - Katsuda, Yousuke

AU - Narishige, Takahiro

AU - Ueno, Hideki

AU - Shimokawa, Hiroaki

AU - Takeshita, Akira

PY - 1994/1/1

Y1 - 1994/1/1

N2 - Objective: The aim was to determine a role of ATP sensitive potassium (KATP) channels in adenosine A2 receptor mediated coronary vasodilatation in anaesthetised dogs in vivo. Methods: Coronary blood flow in the left circumflex coronary artery, aortic pressure, and left ventricular pressure were measured during intracoronary infusions of the drugs into the left circumflex artery. Results: A non-selective A2 receptor agonist NECA (5'-N-ethylcarboxamidoadenosine) at 10-10-10-8 mol·min-1 before and after an A, receptor antagonist DPCPX (8-cyclopentyl-l,3-dipropylxanthine) increased coronary blood flow in a dose dependent manner, without affecting other haemodynamic variables. Glibenclamide at 10 μg·kg-1·min-1, which did not alter baseline haemodynamic variables, markedly inhibited the increases in coronary blood flow caused by NECA alone and after DPCPX (p<0.01). A non-selective adenosine receptor antagonist 8-phenyltheophylline abolished the NECA induced increases in coronary blood flow after DPCPX. These results suggest that A2 receptor mediated coronary vasodilatation was mediated largely by opening of KATP channels. Glibenclamide did not alter the increase in coronary blood flow evoked by forskolin or acetylcholine, suggesting that KATP channels may not be involved in coronary vasodilatation induced by activation of adenylate cyclase or guanylate cyclase. Furthermore, DPCPX increased basal coronary blood flow, which was blocked by 8-phenyltheophylline and by glibenclamide, suggesting that it may have unmasked A2 receptor mediated coronary vasodilatation by inhibiting the A1 receptor mediated vasoconstricting action of endogenous adenosine. Conclusions: Opening of KATP channels may be involved importantly in adenosine A2 receptor mediated coronary vasodilatation in canine hearts.Cardiovascular Research 1994:28:906-911.

AB - Objective: The aim was to determine a role of ATP sensitive potassium (KATP) channels in adenosine A2 receptor mediated coronary vasodilatation in anaesthetised dogs in vivo. Methods: Coronary blood flow in the left circumflex coronary artery, aortic pressure, and left ventricular pressure were measured during intracoronary infusions of the drugs into the left circumflex artery. Results: A non-selective A2 receptor agonist NECA (5'-N-ethylcarboxamidoadenosine) at 10-10-10-8 mol·min-1 before and after an A, receptor antagonist DPCPX (8-cyclopentyl-l,3-dipropylxanthine) increased coronary blood flow in a dose dependent manner, without affecting other haemodynamic variables. Glibenclamide at 10 μg·kg-1·min-1, which did not alter baseline haemodynamic variables, markedly inhibited the increases in coronary blood flow caused by NECA alone and after DPCPX (p<0.01). A non-selective adenosine receptor antagonist 8-phenyltheophylline abolished the NECA induced increases in coronary blood flow after DPCPX. These results suggest that A2 receptor mediated coronary vasodilatation was mediated largely by opening of KATP channels. Glibenclamide did not alter the increase in coronary blood flow evoked by forskolin or acetylcholine, suggesting that KATP channels may not be involved in coronary vasodilatation induced by activation of adenylate cyclase or guanylate cyclase. Furthermore, DPCPX increased basal coronary blood flow, which was blocked by 8-phenyltheophylline and by glibenclamide, suggesting that it may have unmasked A2 receptor mediated coronary vasodilatation by inhibiting the A1 receptor mediated vasoconstricting action of endogenous adenosine. Conclusions: Opening of KATP channels may be involved importantly in adenosine A2 receptor mediated coronary vasodilatation in canine hearts.Cardiovascular Research 1994:28:906-911.

UR - http://www.scopus.com/inward/record.url?scp=85047677008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047677008&partnerID=8YFLogxK

U2 - 10.1093/cvr/28.6.906

DO - 10.1093/cvr/28.6.906

M3 - Article

C2 - 7923297

AN - SCOPUS:85047677008

VL - 28

SP - 906

EP - 911

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 6

ER -